TuHURA Biosciences Unveils Delta Opioid Receptor Role at ASH Annual Meeting TuHURA Biosciences shared groundbreaking findings about the Delta Opioid Receptor at the ASH Annual Meeting, highlighting its potential in cancer immunotherapy.

TuHURA Biosciences Unveils Delta Opioid Receptor Role at ASH Annual Meeting #USA #Orlando #Cancer_Immunotherapy #TuHURA_Biosciences #Delta_Opioid_Receptor

TuHURA Biosciences Presents Groundbreaking Research on Delta Opioid Receptor and Cancer Immunotherapy TuHURA Biosciences announces groundbreaking findings on Delta Opioid Receptor's role in reprogramming immune cells, enhancing cancer treatment effectiveness.

TuHURA Biosciences Presents Groundbreaking Research on Delta Opioid Receptor and Cancer Immunotherapy #USA #Tampa #TuHURA_Biosciences #Delta_Opioid_Receptor #MDSCs